Chapter 26: Coagulation Modifier Drugs Flashcards

1
Q

educate patients about bleeding precautions: electric razor for shaving, soft toothbrush, monitor for bleeding, avoid NSAIDS and ASA

A

anticoagulants (heparin, enoxaparin, warfarin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

route of administration of warfarin

A

oral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

obtain baseline lab work prior to starting the drip

A

heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

this antiplatelet drug is used only as IV

A

eptifibatide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

drug class that primarily prevents arterial clots

A

antiplatelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

prolongs clotting time

A

warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

used to prevent DVT and acute PE after orthopedic or abdominal surgery

A

enoxaparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

used in patients with a higher risk for clotting due to venous or arterial disorders

A

anticoagulants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

prevents thrombi from growing larger in acute thrombosis

A

heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

degrades fibrinogen, fibrin, and other clotting factors disintegrating clot

A

thrombolytics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

prevents venous thrombosis

A

heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

drug class that attacks and dissolves blood clots that have already formed

A

thrombolytics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

drug class that primarily prevents venous clots

A

anticoagulants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

the goal of INR for warfarin therapy is _____

A

2.0-3.0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

drug that inactivates Xa factor, decreasing ability to inactivate thrombin

A

enoxaparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When taking anticoagulants, hold dose and notify provider if _____ exceeds therapeutic range.

A

INR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

drug that inhibits clot formation by inhibiting action of thrombin, which inhibits conversion of fibrinogen to fibrin

A

heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

inhibits hepatic synthesis of vitamin K, thus affecting clotting factors II, VII, IX, and X

A

warfarin

19
Q

drug class that prevents the formation of clots and does not dissolve clots already formed

A

anticoagulants

20
Q

example of foods high in vitamin K

A

dark green leafy vegetables

21
Q

used to PREVENT COMPLICATIONS in certain types of MI

A

enoxaparin

22
Q

contraindicated in patients with strokes, peptic ulcers, and blood anomalies

A

enoxaparin

23
Q

binds to fibrin promoting conversion of plasminogen to plasmin

A

thrombolytics

24
Q

prevents MI, reinfarction following acute MI, and ischemic stroke

A

antiplatelets

25
Q

used to treat DIC

A

heparin

26
Q

monitor for therapeutic ranges of prothrombin time (PT) and international normalized ration (INR)

A

warfarin

27
Q

three side effects of warfarin

A

hemorrhage
hepatitis
overdose/toxicity

28
Q

SERIOUS risk of bleeding from internal and superficial sites

A

thrombolytics

29
Q

can be given at home; aPTT monitoring not necessary

A

enoxaparin

30
Q

two side effects of heparin

A

hemorrhage
heparin-induced thrombocytopenia

31
Q

this drug has multiple medication interactions: collect thorough medication history

A

warfarin

32
Q

contraindicated with hemorrhagic stroke and active internal bleeding

A

thrombolytics

33
Q

this drug requires dosage check with another nurse before administration

A

heparin

34
Q

route of administration of enoxaparin and location

A

subcutaneously in abdomen

35
Q

two routes of administration of heparin

A

subcutaneous, intravenous
(poorly absorbed in GI tract)

36
Q

treats PE, DVT, and thrombolytic stroke

A

thrombolytics

37
Q

educate clients taking warfarin to avoid large amounts of or maintain a consistent intake of _____________ and avoid fluctuations in intake that could impact warfarin action

A

vitamin K

38
Q

used for intermittent claudication

A

antiplatelets

39
Q

prevents MI, PE, and DVT

A

warfarin

40
Q

treats venous thrombosis and thrombus in clients with AFib or prosthetic heart valves

A

warfarin

41
Q

For warfarin overdose, ________ mg of ___________ is given (slowly, fast) via ___________. Once given, it causes warfarin resistance for _______.

A

5-10, phytonadione (vitamin K), slowly, IV infusion, 7 days

42
Q

drug class that prevents platelets from clumping together and inhibits platelet aggregation at onset of clotting process

A

antiplatelets

43
Q

has a lower risk of bleeding than heparin

A

enoxaparin

44
Q

requires serum monitoring of partial thromboplastin time (PTT) and activated partial thromboplastin time (aPTT)

A

heparin